Transient HBV entry into cerebrospinal fluid following blood-brain barrier disruption: a case of HSV-2 encephalitis with polymicrobial detection elucidated by serial targeted next-generation sequencing
- 1Department of Infectious Diseases, Suzhou Kowloon Hospital Shanghai Jiao Tong University School of Medicine, Suzhou, China
- 2Dinfectome Inc., Nanjing, China
Abstract
Introduction: Hepatitis B virus (HBV) is traditionally considered a strictly hepatotropic virus, and its neuroinvasive potential remains controversial. When targeted next-generation sequencing (tNGS) simultaneously detects multiple viruses in the cerebrospinal fluid (CSF), distinguishing the true pathogen from bystander viruses poses a clinical challenge. We report a rare case of herpes simplex virus 2 (HSV-2) encephalitis with concurrent detection of HBV and human gammaherpesvirus 4 (HHV−4) in the CSF, and explore the mechanism of HBV entry into the central nervous system (CNS) through serial tNGS before and after treatment, combined with routine CSF analysis.
Case presentation: A 42-year-old male with untreated hepatitis B presented with acute fever, frontal and temporal headache for 10 days, unresponsive to empirical anti-infective therapy. EEG revealed increased theta activity in bilateral frontal regions after hyperventilation, suggesting encephalitis. Initial CSF analysis (Day 1) showed marked pleocytosis (white blood cells 1849 × 106/L) and hemorrhagic appearance (red blood cells 1000 × 106/L), indicating acute blood-brain barrier (BBB) disruption. CSF tNGS detected sequences for HSV-2, HHV-4 and HBV. High level of serum HBV DNA with positive HBsAg confirmed active HBV replication. The patient was treated with acyclovir and tenofovir alafenamide (TAF). Repeat lumbar puncture (LP) on Day 17 demonstrated normalized CSF parameters (red blood cells 0 × 106/L, white blood cells 143 × 106/L) and no viral sequences on tNGS. Serum HBV DNA decreased by approximately 2 log10 on the same day. The patient showed significant clinical improvement.
Conclusion: Serial CSF tNGS before and after therapy showed synchronous clearance of three viruses with restored BBB integrity and reduced serum HBV DNA, confirming transient passive HBV entry during HSV-2-induced barrier disruption and creating a false polymicrobial picture. These findings highlight serial tNGS as a valuable tool for validating etiological hypotheses and guiding precision therapy in complex CNS infections.
Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12879-026-14206-5.
Related
- Predictive value of persistent cerebrospinal fluid antibodies at 12 months for long-term clinical outcomes in pediatric anti-NMDAR encephalitis: a retrospective cohort study
- Cerebrospinal Fluid Levels of Brain Derived Neurotrophic Factor in Children with Acute Encephalitis Syndrome: A Prospective Observational Study
- Cerebrospinal fluid TNF-α, regional degree centrality, and depressive symptoms after herpes simplex encephalitis: a cross-sectional observational study
- Human herpesvirus 7-associated encephalitis diagnosed by metagenomic next-generation sequencing in pediatric patients: a retrospective study
- Diagnosis of leptomeningeal metastasis with concurrent tuberculous meningitis assisted by cerebrospinal fluid metagenomic next-generation sequencing combined with copy number variation analysis: a case report
BibTeX
@article{leng2026transient,
title = {{Transient HBV entry into cerebrospinal fluid following blood-brain barrier disruption: a case of HSV-2 encephalitis with polymicrobial detection elucidated by serial targeted next-generation sequencing}},
author = {Xuejun Leng and Yongku Li and Lijuan Gao and Xinying Dong and Jianxue Wang},
journal = {BMC Infectious Diseases},
year = {2026},
month = aug,
doi = {10.1186/s12879-026-14206-5},
url = {https://doi.org/10.1186/s12879-026-14206-5},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Transient HBV entry into cerebrospinal fluid following blood-brain barrier disruption: a case of HSV-2 encephalitis with polymicrobial detection elucidated by serial targeted next-generation sequencing
AU - Xuejun Leng
AU - Yongku Li
AU - Lijuan Gao
AU - Xinying Dong
AU - Jianxue Wang
PY - 2026
DA - 2026/08/10
JO - BMC Infectious Diseases
DO - 10.1186/s12879-026-14206-5
UR - https://doi.org/10.1186/s12879-026-14206-5
AB - Introduction: Hepatitis B virus (HBV) is traditionally considered a strictly hepatotropic virus, and its neuroinvasive potential remains controversial. When targeted next-generation sequencing (tNGS) simultaneously detects multiple viruses in the cerebrospinal fluid (CSF), distinguishing the true pathogen from bystander viruses poses a clinical challenge. We report a rare case of herpes simplex virus 2 (HSV-2) encephalitis with concurrent detection of HBV and human gammaherpesvirus 4 (HHV−4) in the CSF, and explore the mechanism of HBV entry into the central nervous system (CNS) through serial tNGS before and after treatment, combined with routine CSF analysis. Case presentation: A 42-year-old male with untreated hepatitis B presented with acute fever, frontal and temporal headache for 10 days, unresponsive to empirical anti-infective therapy. EEG revealed increased theta activity in bilateral frontal regions after hyperventilation, suggesting encephalitis. Initial CSF analysis (Day 1) showed marked pleocytosis (white blood cells 1849 × 106/L) and hemorrhagic appearance (red blood cells 1000 × 106/L), indicating acute blood-brain barrier (BBB) disruption. CSF tNGS detected sequences for HSV-2, HHV-4 and HBV. High level of serum HBV DNA with positive HBsAg confirmed active HBV replication. The patient was treated with acyclovir and tenofovir alafenamide (TAF). Repeat lumbar puncture (LP) on Day 17 demonstrated normalized CSF parameters (red blood cells 0 × 106/L, white blood cells 143 × 106/L) and no viral sequences on tNGS. Serum HBV DNA decreased by approximately 2 log10 on the same day. The patient showed significant clinical improvement. Conclusion: Serial CSF tNGS before and after therapy showed synchronous clearance of three viruses with restored BBB integrity and reduced serum HBV DNA, confirming transient passive HBV entry during HSV-2-induced barrier disruption and creating a false polymicrobial picture. These findings highlight serial tNGS as a valuable tool for validating etiological hypotheses and guiding precision therapy in complex CNS infections. Supplementary Information: The online version contains supplementary material available at https://doi.org/10.1186/s12879-026-14206-5.
SN - 1471-2334
ER -